Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$558K Buy
59,800
+121
+0.2% +$1.13K ﹤0.01% 1775
2026
Q1
$597K Sell
59,679
-2,446
-4% -$25.4K ﹤0.01% 1601
2025
Q4
$628K Buy
62,125
+9,390
+18% +$89.3K ﹤0.01% 1489
2025
Q3
$477K Sell
52,735
-533
-1% -$5.13K ﹤0.01% 1474
2025
Q2
$552K Buy
53,268
+6,222
+13% +$65.6K ﹤0.01% 1307
2025
Q1
$481K Sell
47,046
-15,491
-25% -$152K 0.01% 1152
2024
Q4
$588K Buy
62,537
+9,617
+18% +$94.1K 0.01% 1009
2024
Q3
$560K Buy
52,920
+13,160
+33% +$127K 0.01% 815
2024
Q2
$328K Buy
39,760
+27,257
+218% +$228K 0.01% 682
2024
Q1
$113K Buy
+12,503
New +$104K 0.02% 475

Other funds holding HLN

&Partners's HLN Position: Q2 2026 in Review

&Partners increased its Haleon (HLN) stake by 0.2% in Q2 2026, buying an estimated $1.13K and bringing the position to 59,800 shares worth $558K. The position accounts for ﹤0.01% of the portfolio, ranked #1775.

&Partners first reported a position in HLN in Q1 2024 and has held it in 10 quarters since. The position peaked at $628K in Q4 2025. 639 funds tracked by Wall St. Rank hold HLN as of Q2 2026.

  • &Partners held 59,800 shares of Haleon worth $558K as of Q2 2026.
  • &Partners bought 121 Haleon shares in Q2 2026, an estimated $1.13K.
  • Haleon made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #1775 holding.
  • &Partners first reported a position in Haleon in Q1 2024 and has held it in 10 quarters since.
  • &Partners's Haleon position peaked at $628K in Q4 2025.
  • 639 funds tracked by Wall St. Rank held Haleon as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.